Progressive Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis
Jonathan A. Rose(Brigham and Women's Hospital), Gary M. Hunninghake(Hubei University of Science and Technology), Maria A. Planchart Ferretto(Brigham and Women's Hospital), Mary B. Rice(Beth Israel Deaconess Medical Center), Iván O. Rosas(Brigham and Women's Hospital), Rachel K. Putman(Brigham and Women's Hospital), Benjamin A. Raby(Brigham and Women's Hospital), Hiroto Hatabu(Harvard University), Swati Gulati(Pulmonary and Critical Care Associates), Anthony H. Maeda, Maria F. Perez Garcia(Baylor College of Medicine), Nikkola Carmichael(Boston University), Hilary J. Goldberg(Harvard University)
American Journal of Respiratory and Critical Care Medicine
September 13, 2022
Cited by 19
Related Papers
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2012|1.3k
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
|New England Journal of Medicine|2011|1.1k
Serum Vitamin D Levels and Markers of Severity of Childhood Asthma in Costa Rica
|American Journal of Respiratory and Critical Care Medicine|2009|635
Lung Volumes and Emphysema in Smokers with Interstitial Lung Abnormalities
|New England Journal of Medicine|2011|615
MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis
|PLoS Medicine|2008|599